Murad Alahdal
Murad Alahdal is an expert in Biochemistry at Johns Hopkins All Children's Hospital (United States). Murad Alahdal has authored 37 publications, the most recent in 2023. SLR score: 114 (community average: 125). How the SLR is computed.
LeadR Profile
Biochemistry
Subspecialties:
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2009 - 2024
Number : 37
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Exosomes loaded with chondrogenic stimuli agents combined with 3D bioprinting hydrogel in the treatment of osteoarthritis and cartilage degeneration. PMID 37857246 — cartilage, drug therapy, cells, therapeutics, chondrocytes, exosomes, research, osteoarthritis, tissues, hydrogels, hydrogel, polyethylene glycol dimethacrylate, bioprinting | Biomed Pharmacother | 2023 | 14 |
| Non-coding RNAs in cancer immunotherapy: Predictive biomarkers and targets. PMID 37735815 — cells, vaccines, neoplasms, biomarkers, immunotherapy, clinical medicine, antibodies, monoclonal, therapeutics, t-lymphocytes, cancer vaccines, b-lymphocytes, plasma, car-t cell | Clin Transl Med | 2023 | 32 |
| Current advances of liquid biopsies in prostate cancer: Molecular biomarkers. PMID 37575217 — diagnosis, biomarkers, neoplasm metastasis, dna, prostatic neoplasms, prostate-specific antigen, rna, untranslated, liquid biopsy | Mol Ther Oncolytics | 2023 | 18 |
| Role of exosomal ncRNAs released by M2 macrophages in tumor progression of gastrointestinal cancers. PMID 36968082 — drug resistance, immunosuppression therapy, macrophages, neoplasm metastasis, neoplasms | iScience | 2023 | 4 |
| Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities. PMID 36356848 — infections, immune system diseases, allergy and immunology, therapeutics, antigen-presenting cells, covid-19, sars-cov-2 | Clin Immunol | 2022 | 30 |
LeadR Networks
Main global connection map